ФАО АГРИС — международная информационная система по сельскохозяйственным наукам и технологиям

ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole

2010

Smollich, Martin | Götte, Martin | Fischgräbe, Jeanett | Macedo, Luciana F | Brodie, Angela | Chen, Shiuan | Radke, Isabel | Kiesel, L. | Wülfing, Pia


Библиографическая информация
Издатель
American Society for Nutrition
Другие темы
Time factors; Cell movement; Tamoxifen; Breast neoplasms; Dose-response relationship; Drug; Breast neoplasms; Endothelin a; Endothelin-1; Neoplastic; Endothelin; Endothelin a receptor antagonists; Ednra; Cell line; Tumor; Female; Estrogen antagonists; Antineoplastic combined chemotherapy protocols; Cell proliferation; Neoplasm invasiveness; Zd4054; Administration & dosage; Tumor burden; Analogs & derivatives; Drug effects; Aromatase inhibitors; Nude; Et-1; Aromatase inhibitors; Nitriles; Xenograft model antitumor assays; Pyrrolidines
Язык
Английский
Тип
Journal Article; Text

2024-02-29
MODS
Посмотрите в Google Scholar
If you notice any incorrect information relating to this record, please contact us at [email protected] [email protected]